Academic history
Christopher Gibson, MD, obtained his medical degree from Yale University School of Medicine, CT, in 2009 and trained as a resident in internal medicine at Brigham and Women’s Hospital, MA, where he was also Chief Medical Resident. He completed his fellowship in hemato-oncology at the Dana-Farber Cancer Institute, MA, in 2019 where he currently works as a Consultant.
Speaking on lymphoma, leukemia and ASCT
Dr Gibson’s research focuses on the treatment of leukemias, Hodgkin and non-Hodgkin lymphoma, and myelodysplastic and myeloproliferative diseases. His work has been centred around the effect of genetic mutations on patient outcomes amongst patients undergoing bone marrow transplants.
Sorry, no posts matched your criteria.
